Algorae Pharmaceuticals (ASX:1AI) has won a NSW Health public hospital supply contract, validating the AlgoraeRx commercial strategy with a 3+1+1 year term.
AI Stocks
The shifting global situation is forcing a massive rethink of manufacturing geography. Defense spending is more than buying a hardware today, and it is all about guaranteeing that critical physical components are born, bred, and secured locally. While mega-caps capture the headline contracts, there are 3 overlooked ASX micro-caps are quietly monopolizing highly technical niches…
Today is the first day of the new financial year, and we think plenty of investors are wondering which ASX Stocks to Buy in FY27. Stocks Down Under recaps 10 stocks that it thinks is set for a good 12 months ahead.
10 ASX Stocks to Buy in FY27
Goodman Group (ASX:GMG)
Goodman enters FY27 with…
How much AI spend is your stock splurging? If the company doesn’t tell you, here are 5 ways to tell!
AI spend is surging faster than any other technological development in history. There are varying estimates of just how much and one of the reasons is that most refuse to disclose the number. Yes there are others such as numbers shifting quickly for those that do disclose.
But even though we'd all be rich if we…
FortifAI (ASX:FTI) lists Nol8 on the Megaport AI Exchange with live customer POCs, pulling the commercial timeline forward.
X2M Connect (ASX:X2M) hires ex-Optus smart cities lead Dr Sajjad Ahmed and Tabcorp veteran Kate O’Sullivan to deliver its Australian pipeline.
Market dislocation is punishing Microsoft while rewarding similar AI spend elsewhere
The AI trade is starting to split into winners and supposed losers, but the market may be drawing that line too quickly.
Microsoft’s (NASDAQ:MSFT) recent valuation pressure looks strange when compared with how investors are treating Google, Amazon and parts of the semiconductor market. D.A.…
Australian AI company Firmus Technologies has signed a major partnership with chip giant Nvidia to build a 360MW AI factory in Batam, Indonesia, alongside Singapore's DayOne. The deal uses 170,000 Nvidia GPUs and targets up to US$30 billion in revenue over six years. That is a huge number for a company most Australians have never…
FortifAI (ASX:FTI) ships Nol8 AI Data Plane V1.0 ahead of its February roadmap, opening NeoCloud design partner testing for agentic AI workloads.
The AI IPO boom that felt unstoppable just hit a wall. SpaceX, the year's blockbuster float, listed at US$135, raced to nearly US$226, then slid back to around US$153. Now OpenAI is reportedly leaning towards pushing its own listing to 2027, with chief executive Sam Altman holding out for a US$1 trillion valuation rather than…
